Goldman Sachs’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.42M Buy
3,316,453
+2,295,559
+225% +$2.92M ﹤0.01% 4242
2026
Q2
$1.56M Sell
1,020,894
-106,512
-9% -$162K ﹤0.01% 4869
2026
Q1
$2.04M Sell
1,127,406
-1,175,069
-51% -$2.03M ﹤0.01% 4535
2025
Q4
$3.11M Buy
2,302,475
+2,204,765
+2,256% +$3.14M ﹤0.01% 4199
2025
Q3
$159K Sell
97,710
-789,342
-89% -$875K ﹤0.01% 5996
2025
Q2
$861K Buy
887,052
+286,373
+48% +$238K ﹤0.01% 4808
2025
Q1
$424K Sell
600,679
-225,168
-27% -$156K ﹤0.01% 5281
2024
Q4
$665K Sell
825,847
-106,890
-11% -$97.9K ﹤0.01% 5075
2024
Q3
$925K Buy
932,737
+173,297
+23% +$238K ﹤0.01% 4686
2024
Q2
$1.18M Sell
759,440
-1,848,185
-71% -$2.88M ﹤0.01% 4331
2024
Q1
$4.28M Buy
+2,607,625
New +$2.19M ﹤0.01% 3237
2023
Q3
– Sell
-70,669
Closed -$38.4K – 5763
2023
Q2
$38.4K Sell
70,669
-634,231
-90% -$407K ﹤0.01% 5488
2023
Q1
$601K Sell
704,900
-840,315
-54% -$916K ﹤0.01% 4728
2022
Q4
$2.01M Sell
1,545,215
-448,705
-23% -$699K ﹤0.01% 3944
2022
Q3
$3.55M Buy
1,993,920
+416,256
+26% +$1.04M ﹤0.01% 3454
2022
Q2
$3.58M Buy
1,577,664
+596,736
+61% +$1.43M ﹤0.01% 3504
2022
Q1
$3.24M Buy
980,928
+760,306
+345% +$2.67M ﹤0.01% 3775
2021
Q4
$1M Sell
220,622
-4,777
-2% -$36.1K ﹤0.01% 4834
2021
Q3
$1.62M Sell
225,399
-7,151
-3% -$52.5K ﹤0.01% 4373
2021
Q2
$1.87M Sell
232,550
-94,018
-29% -$793K ﹤0.01% 4268
2021
Q1
$2.22M Buy
326,568
+315,310
+2,801% +$2.1M ﹤0.01% 3887
2020
Q4
$21K Buy
+11,258
New +$5.42K ﹤0.01% 5435
2017
Q3
– Sell
-196
Closed -$21K – 6789
2017
Q2
$21K Buy
+196
New +$20.1K ﹤0.01% 6547
2015
Q4
– Sell
-193
Closed -$46K – 7283
2015
Q3
$46K Sell
193
-153
-44% -$55.3K ﹤0.01% 6821
2015
Q2
$134K Sell
346
-357
-51% -$172K ﹤0.01% 6443
2015
Q1
$422K Buy
703
+211
+43% +$122K ﹤0.01% 5310
2014
Q4
$325K Buy
+492
New +$325K ﹤0.01% 5705

Other funds holding OCGN

Goldman Sachs's OCGN Position: Q3 2026 in Review

Goldman Sachs increased its Ocugen (OCGN) stake by 225% in Q3 2026, buying an estimated $2.92M and bringing the position to 3,316,453 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #4242.

Goldman Sachs first reported a position in OCGN in Q4 2014 and has held it in 27 quarters since. The position peaked at $4.28M in Q1 2024. 147 funds tracked by Wall St. Rank hold OCGN as of Q3 2026.

  • Goldman Sachs held 3,316,453 shares of Ocugen worth $3.42M as of Q3 2026.
  • Goldman Sachs bought 2,295,559 Ocugen shares in Q3 2026, an estimated $2.92M.
  • Ocugen made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #4242 holding.
  • Goldman Sachs first reported a position in Ocugen in Q4 2014 and has held it in 27 quarters since.
  • Goldman Sachs's Ocugen position peaked at $4.28M in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.